Argenica Therapeutics Limited (ASX:AGN)
Australia
· Delayed Price · Currency is AUD 0.200
-0.020 (-9.09%)
At close: Mar 9, 2026
Argenica Therapeutics Market Cap
Argenica Therapeutics has a market cap or net worth of 25.69 million as of March 9, 2026. Its market cap has decreased by -74.29% in one year.
Market Cap
25.69M
Enterprise Value
20.65M
Revenue
1.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.20
Market Cap Chart
Since June 11, 2021, Argenica Therapeutics's market cap has increased from 19.02M to 25.69M, an increase of 35.04%. That is a compound annual growth rate of 6.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 25.69M | -32.20% |
| Dec 31, 2025 | 37.89M | -53.04% |
| Dec 31, 2024 | 80.70M | 59.59% |
| Dec 29, 2023 | 50.57M | 29.28% |
| Dec 30, 2022 | 39.12M | -35.98% |
| Dec 31, 2021 | 61.10M | 221.15% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeuroScientific Biopharmaceuticals | 32.26M |
| Algorae Pharmaceuticals | 23.91M |
| Noxopharm | 18.74M |
| Patrys | 18.74M |
| Avecho Biotechnology | 44.08M |
| Neurotech International | 16.85M |
| EZZ Life Science Holdings | 51.07M |
| Entropy Neurodynamics | 53.31M |